Scandinavian Pen Peptide
CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Blend
CJC-1295 No DAC (5mg) + Ipamorelin (10mg) | Blend
Couldn't load pickup availability
- Purity ≥98% for precise research protocols
- Delivery with DHL Express in a thermo-insulated package
- Secure payment by bank transfer
CJC-1295 No DAC + Ipamorelin — Synergistic Blend
This blend combines two complementary peptides for a synergistic action on growth hormone production. CJC-1295 no DAC is a GHRH analogue that stimulates the pituitary gland to release natural growth hormone, with a shorter duration of action allowing for precise control of GH secretion.
Ipamorelin is a modern GH secretagogue that acts as a selective ghrelin receptor agonist. Unlike other secretagogues, it does not cause a significant increase in cortisol or prolactin, does not strongly stimulate appetite, and is very well tolerated. These properties make it one of the most popular peptides in regeneration and anti-aging biology research.
Why combine these two peptides?
The combination produces a synergistic effect on growth hormone production. While CJC-1295 no DAC stimulates the pituitary gland, Ipamorelin activates receptors that enhance pulsatile GH secretion. This combination can lead to a more regular and physiological GH release than using individual peptides, and is frequently studied in the context of physical performance, recovery, metabolism, and age-related changes.
Potential Benefits
Stimulation of GH secretion can support protein synthesis and muscle development, promote fat metabolism and lipolysis, accelerate tissue repair and recovery after physical exertion, improve sleep quality, and support skin quality, bone structure, and cellular regeneration.
Dosage and Use
Typically, 10 to 14 units per day are used, i.e., 5 to 7 units in the morning and 5 to 7 units in the evening. The injection is administered subcutaneously in the abdominal area or the front of the thigh. Leave the needle in place for approximately 10 seconds before removing it and regularly change injection sites. A typical research cycle lasts 4 to 6 months.
One pen contains 200 units with 25 µg of CJC-1295 no DAC and 50 µg of Ipamorelin per unit, and lasts approximately 20 days with the usual dosage. Examples: 1 unit = 25 µg CJC + 50 µg Ipa — 5 units = 125 µg / 250 µg — 10 units = 250 µg / 500 µg.
Partager
